+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Bacteremia Drug"

Staphylococcus aureus Bacteremia - Pipeline Insight, 2024 - Product Thumbnail Image

Staphylococcus aureus Bacteremia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
Bacteremia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Bacteremia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Bacteremia is a type of infection caused by bacteria entering the bloodstream. It is a serious condition that can lead to sepsis and other life-threatening complications. Treatment for bacteremia typically involves antibiotics, which are drugs that kill or inhibit the growth of bacteria. Infectious diseases drugs are a class of medications used to treat a variety of bacterial, viral, and fungal infections. These drugs are used to treat a wide range of conditions, including bacteremia. The bacteremia drug market is a subset of the larger infectious diseases drug market. It includes a variety of antibiotics, such as penicillins, cephalosporins, macrolides, and fluoroquinolones, as well as other drugs used to treat bacteremia. These drugs are used to treat both acute and chronic bacteremia, and are available in both oral and intravenous formulations. Some companies in the bacteremia drug market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and AstraZeneca. These companies produce a variety of antibiotics and other drugs used to treat bacteremia. Show Less Read more